Medical News

RSS

BioSTAR biodegradable implant achieves comparable closure rates to Amplatzer ASO

A novel study by Canadian physicians reported that the BioSTARTM biodegradable implant achieved comparable closure rates to the Amplatzer Septal OccluderTM (ASO) in children with atrial septal defect (ASD). The BioSTAR device displayed successful outcomes, while avoiding issues associated with implants containing substantial amounts of metal.

16 Jul 2010

New findings on macrophage activation can facilitate development of early diagnosis tools

Immune system cells called macrophages spring into action to surround and destroy threats such as viruses or cancer cells. But sometimes the would-be protective response leads to persistent inflammation, which, in turn, can cause disease.Scientists don't know exactly how macrophages cross the line from being good cops to bad cops, but researchers at the University of Florida recently unearthed several clues about the mechanisms involved. Through the lens of two inflammation-related diseases, HIV and rheumatoid arthritis, they identified changes in specific proteins linked to the action of macrophages, white blood cells that are key to the body's natural defenses.

16 Jul 2010

Cubist Pharmaceuticals total net revenues for second-quarter 2010 increase 29%

Cubist Pharmaceuticals, Inc. today announced results for the second quarter ended June 30, 2010.

16 Jul 2010

KHN column – Behind the scenes of health reform: The National Association of Insurance Commissioners

In this Kaiser Health News column, Timothy Jost writes: "The new health reform act has been widely criticized as a federal government takeover of the health care system. To a remarkable degree, however, the law actually relies on the states to reform health insurance" (7/15).

16 Jul 2010

ACTOS offers safety profile regarding risk of CV events in people with type 2 diabetes: Takeda

The U.S. Food and Drug Administration Endocrinologic and Metabolic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee held a joint meeting primarily focused on reviewing the cardiovascular safety of rosiglitazone, as presented by the FDA and GlaxoSmithKline. Following this two day discussion, Takeda Pharmaceuticals North America, Inc. ("Takeda") underscores its position that ACTOS (pioglitazone HCl) offers an established safety profile regarding the risk of CV events in people living with type 2 diabetes.

16 Jul 2010

Elusys, Lonza partner for commercial production of Anthim antibody for inhaled anthrax treatment

Elusys Therapeutics and Lonza today announced an agreement for the scale-up and commercial production of Anthim, a therapeutic monoclonal antibody in late-stage development for the treatment of inhaled anthrax. Under the new contract, Lonza will provide process scale-up, technology transfer, validation, and commercial manufacturing at one of its facilities in the USA. The manufacturing process for Anthim was optimized for full scale production by Lonza under a separate agreement announced in 2009.

16 Jul 2010

Federal task force on preventive care faces new challenge under health law

Kaiser Health News staff writer Christopher Weaver, working in collaboration with The Washington Post, reports: "For years, an obscure federal task force sifted through medical literature ranging from colonoscopies to fluoride treatment, ferreting out the best evidence for doctors to use in caring for their patients. But now its recommendations have new financial implications, raising the stakes for patients, physicians and others in the health care industry"

16 Jul 2010

Abortion opponents say that elective abortions may be covered in high risk pools

Abortion opponents worry that vague language used in the new health care reform bill could lead to the coverage of elective abortions in new high risk insurance pools and say that may already be starting in New Mexico and Pennsylvania.

16 Jul 2010

Professor develops sensor to better regulate fluid flow in hydrocephalus

Hydrocephalus, or "water on the brain" as it is often called, is a condition that is diagnosed in tens of thousands in the U.S. every year, causing symptoms from mild gait problems to life-threatening seizures.

16 Jul 2010

Glaxo announces a $2.3 billion in legal liability charges

British pharmaceutical giant GlaxoSmithKline, announced this Thursday that its second-quarter charges related to legal cases involving the two drugs Avandia (diabetes drug) and Paxil (drug for anxiety and depression) would run up to $2.36 billion. Avandia’s use and its potential risk of causing heart problems were being debated this week by an advisory panel to the US Food & Drugs Administration (FDA).

16 Jul 2010

Amnesty International reveals the rotting health care system in North Korea

According to a human rights group, Amnesty International, North Korea is unable to meet up to even the most basic health needs of its population. The report was released this Thursday.

15 Jul 2010

$235 million announced for expansion of biotech sector at CSL

A $235 million expansion of Australia's largest biotech facility in Melbourne is planned and this is expected to create hundreds of jobs. CSL biopharmaceutical research complex in Broadmeadows, in the north of Melbourne will be receiving this financial aid from both the State as well as Federal government over a five year investment plan. This will create an estimated 320 temporary construction jobs and later 333 new highly-skilled medical research openings by 2018.

15 Jul 2010

Rapid weight loss the best: Study

Researchers have now shown that the best way to lose weight is to lose a lot of it at once contrary to popular belief even among doctors that weight should be lost slowly.

15 Jul 2010

DaVita to locate new headquarters building in a lot adjacent to Millennium Bridge

DaVita Inc., a leading provider of kidney care services for those diagnosed with chronic kidney disease, announced today it will locate its new headquarters building in a lot adjacent to the Millennium Bridge, at the west end of the 16th Street Mall, across from the new Union Station development. Construction will begin in early 2011 and DaVita expects to begin occupying the building in the second half of 2012.

15 Jul 2010

8.8% of drug-related hospital emergency department visits by adolescents is a suicide attempt

A new series of studies analyzing drug-related hospital emergency department visits throughout the country during 2008 reveals a substantial percentage of these visits involve suicide attempts. According to these studies conducted by the Substance Abuse and Mental Health Services Administration (SAMHSA) more than one in every twelve (8.8 percent) drug-related hospital emergency department visit by an adolescent is a suicide attempt - double the rate found among cases involving those age 25 and older (4.4 percent).

15 Jul 2010

Pitney Bowes to deliver customized mailing solutions to RCP

Pitney Bowes Inc. today announced that Revenue Cycle Partners, a leading business process outsource provider for hospitals and healthcare systems nationwide, has chosen Pitney Bowes for customized mailing solutions to further deliver world-class BPO services to its hospital client base while helping to ensure the highest level of healthcare privacy compliance.

15 Jul 2010

QR Pharma to present positive clinical data from mechanism of action study in MCI at ICAD 2010

QR Pharma, Inc., a developer of novel drugs to treat Alzheimer's disease (AD), is presenting a poster today on positive clinical data from its recent mechanism of action study in mild cognitive impaired (MCI) patients at the International Congress on Alzheimer's Disease (ICAD 2010).

15 Jul 2010

Scientists gather to discuss latest advances in Alzheimer's disease at AAICAD 2010

This week, nearly 4,000 scientists from around the world gathered to report and discuss the latest advances in research on treatments, risk factors, and diagnosis for the health epidemic of the 21st century – Alzheimer's disease – at the Alzheimer's Association's 2010 International Conference on Alzheimer's Disease in Honolulu.

15 Jul 2010

Shrink Nanotechnologies files patent applications for CellAlign advanced tissue engineering technology

Shrink Nanotechnologies, Inc., an innovative nanotechnology company developing products and licensing opportunities in the solar energy production, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that certain patent applications related to its advanced tissue engineering technology platform, CellAlign™, have been filed.

15 Jul 2010

Practice Fusion API Challenge kicked off

Practice Fusion, the free, web-based Electronic Health Record company, kicked off the Practice Fusion API Challenge today as part of the Health 2.0 Developer Challenge, an initiative supported by the US Department of Health and Human Services. The challenge invites developers to connect patient health data from medical devices, mobile apps, social media systems and websites to doctors in real-time through Practice Fusion's new API.

15 Jul 2010

Medical News

BioSTAR biodegradable implant achieves comparable closure rates to Amplatzer ASO

New findings on macrophage activation can facilitate development of early diagnosis tools

Cubist Pharmaceuticals total net revenues for second-quarter 2010 increase 29%

KHN column – Behind the scenes of health reform: The National Association of Insurance Commissioners

ACTOS offers safety profile regarding risk of CV events in people with type 2 diabetes: Takeda

Elusys, Lonza partner for commercial production of Anthim antibody for inhaled anthrax treatment

Federal task force on preventive care faces new challenge under health law

Abortion opponents say that elective abortions may be covered in high risk pools

Professor develops sensor to better regulate fluid flow in hydrocephalus

Glaxo announces a $2.3 billion in legal liability charges

Amnesty International reveals the rotting health care system in North Korea

$235 million announced for expansion of biotech sector at CSL

Rapid weight loss the best: Study

DaVita to locate new headquarters building in a lot adjacent to Millennium Bridge

8.8% of drug-related hospital emergency department visits by adolescents is a suicide attempt

Pitney Bowes to deliver customized mailing solutions to RCP

QR Pharma to present positive clinical data from mechanism of action study in MCI at ICAD 2010

Scientists gather to discuss latest advances in Alzheimer's disease at AAICAD 2010

Shrink Nanotechnologies files patent applications for CellAlign advanced tissue engineering technology

Practice Fusion API Challenge kicked off

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News